Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 15563562)

Published in J Am Soc Nephrol on November 24, 2004

Authors

Wolfgang C Winkelmayer1, Reinhard Kramar, Gary C Curhan, Anil Chandraker, Georg Endler, Manuela Födinger, Walter H Hörl, Gere Sunder-Plassmann

Author Affiliations

1: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA. wolfgang@post.harvard.edu

Articles by these authors

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med (2007) 9.51

Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99

Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol (2006) 6.66

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32

Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2010) 5.50

Obesity, weight gain, and the risk of kidney stones. JAMA (2005) 5.34

Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95

Urologic diseases in America project: urolithiasis. J Urol (2005) 4.90

Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46

The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity (2008) 4.44

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant (2004) 4.27

Diet and lifestyle risk factors associated with incident hypertension in women. JAMA (2009) 3.94

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA (2005) 3.88

Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med (2008) 3.87

Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med (2009) 3.76

Frequency of analgesic use and risk of hypertension among men. Arch Intern Med (2007) 3.29

History of kidney stones and the risk of coronary heart disease. JAMA (2013) 3.23

Diabetes mellitus and the risk of nephrolithiasis. Kidney Int (2005) 3.17

Current issues in measurement and reporting of urinary albumin excretion. Clin Chem (2008) 2.98

Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci (2008) 2.98

Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc (2005) 2.86

Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med (2011) 2.85

Prevalence and characteristics of tinnitus among US adults. Am J Med (2010) 2.84

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension (2008) 2.81

The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo. J Immunol (2011) 2.69

Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol (2004) 2.60

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int (2012) 2.38

The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. J Immunol (2011) 2.34

Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol (2002) 2.34

Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation (2004) 2.33

Change in prevalence of hearing loss in US adolescents. JAMA (2010) 2.32

Body size and 24-hour urine composition. Am J Kidney Dis (2006) 2.27

Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation (2006) 2.26

Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol (2006) 2.19

Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension (2002) 2.16

Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ (2012) 2.14

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation (2005) 2.13

Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol (2008) 2.07

Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ (2014) 2.06

Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol (2006) 2.06

Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol (2002) 2.02

Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care (2006) 1.96

Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int (2002) 1.96

DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol (2009) 1.93

The association between mental health, physical function, and hemodialysis mortality. Kidney Int (2003) 1.93

Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol (2009) 1.91

Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J (2007) 1.87

Shorter length dialysis sessions are associated with increased mortality, independent of body weight. Kidney Int (2012) 1.84

Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology (2002) 1.83

Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol (2013) 1.82

Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol (2008) 1.82

Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant (2002) 1.81

A prospective study of cardiovascular risk factors and incident hearing loss in men. Laryngoscope (2010) 1.80

D-dimer in ruling out acute aortic dissection: a systematic review and prospective cohort study. Eur Heart J (2007) 1.79

C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem (2007) 1.79

Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol (2006) 1.76

Diet-dependent net acid load and risk of incident hypertension in United States women. Hypertension (2009) 1.75

Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol (2011) 1.74

The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med (2003) 1.71

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol (2003) 1.70

Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol (2007) 1.70

Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum (2004) 1.69

Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet (2012) 1.68

Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension (2005) 1.68

Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain. Clin J Am Soc Nephrol (2013) 1.67

Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology (2008) 1.66

DASH-style diet and 24-hour urine composition. Clin J Am Soc Nephrol (2010) 1.65

Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65

Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol (2013) 1.65

Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ (2009) 1.61

Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma (2005) 1.61

Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem (2002) 1.59

Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol (2009) 1.59

Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria. J Am Soc Nephrol (2012) 1.59

Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here? Nephrol Dial Transplant (2004) 1.59

Kidney stones and kidney function loss: a cohort study. BMJ (2012) 1.58

Determinants of plasma parathyroid hormone levels in young women. Calcif Tissue Int (2010) 1.58

Intake of n-6 and n-3 fatty acids and fish and risk of community-acquired pneumonia in US men. Am J Clin Nutr (2005) 1.57

Heavy metals exposure and hearing loss in US adolescents. Arch Otolaryngol Head Neck Surg (2011) 1.57

Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol (2004) 1.56

Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem (2007) 1.56

Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr (2006) 1.55

Plasma resistin levels associate with risk for hypertension among nondiabetic women. J Am Soc Nephrol (2010) 1.54

Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol (2008) 1.54

Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit Care Med (2002) 1.53

Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol (2004) 1.53

Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest (2005) 1.52

Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta. Mol Genet Metab (2008) 1.52

The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. J Invest Dermatol (2006) 1.52

Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation (2005) 1.51